Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 71,821 |
|
|||||
| News | - | ||||||
| Day High | 13.59 | Low High |
|||||
| Day Low | 12.81 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Mineralys Therapeutics Inc | MLYS | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.14 | -1.07% | 12.95 | 23:00:03 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 13.59 | 12.81 | 13.59 | 12.95 | 13.09 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,451 | 71,821 | US$ 13.08 | US$ 939,626 | - | 5.85 - 17.70 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 16:30:08 | 1 | US$ 13.5279 | USD |
Mineralys Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 532.31M | 41.11M | - | 0 | -71.9M | -1.75 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Mineralys Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MLYS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 11.17 | 13.59 | 11.17 | 12.61 | 156,423 | 1.78 | 15.94% |
| 1 Month | 12.93 | 13.7499 | 10.37 | 12.20 | 126,019 | 0.02 | 0.15% |
| 3 Months | 14.15 | 16.905 | 10.37 | 13.58 | 150,334 | -1.20 | -8.48% |
| 6 Months | 8.03 | 16.905 | 5.85 | 10.82 | 171,616 | 4.92 | 61.27% |
| 1 Year | 13.59 | 17.70 | 5.85 | 12.01 | 173,629 | -0.64 | -4.71% |
| 3 Years | 21.10 | 21.98 | 5.85 | 13.06 | 184,824 | -8.15 | -38.63% |
| 5 Years | 21.10 | 21.98 | 5.85 | 13.06 | 184,824 | -8.15 | -38.63% |
Mineralys Therapeutics Description
| Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and associated cardiovascular diseases. It clinical-stage product candidate is lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase inhibitor for the treatment of patients with uncontrolled or resistant hypertension. The company was incorporated in 2019 and is headquartered in Radnor, Pennsylvania. |
